Jul 22, 2009 - Depomed, Inc. today announced that it has provided a license to certain patents directed to metformin extended release technology to Merck & Co., Inc. to be used in developing fixed dose combinations of sitagliptin and extended release metformin.
The details can be read here.
No comments:
Post a Comment